Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells-Reference-Cited by-同舟云学术

Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells

Published:2018-06 Issue: Volume:99 Page:1-9
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Momeny Majid,Yousefi Hassan,Eyvani Haniyeh,Moghaddaskho Farima,Salehi Ali,Esmaeili Fatemeh,Alishahi Zivar,Barghi Farinaz,Vaezijoze Somaye,Shamsaiegahkani Sahar,Zarrinrad Ghazaleh,Sankanian Ghazaleh,Sabourinejad Zahra,Hamzehlou Sepideh,Bashash Davood,Aboutorabi Elaheh S.,Ghaffari Parisa,Dehpour Ahmad R.,Tavangar Seyyed M.,Tavakkoly-Bazzaz Javad,Alimoghaddam Kamran,Ghavamzadeh Ardeshir,Ghaffari Seyed H.

Funder

Hematology/Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference73 articles.

1. Clinical update: novel targets in gynecologic malignancies;Aghajanian;Semin. Oncol.,2004

2. Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancer;Aghajanian;J. Clin. Oncol.,2005

3. Recent insights into the role of NF-kappaB in ovarian carcinogenesis;Alvero;Genome Med.,2010

4. NF-κB transcription factors are co-expressed and convey poor outcome in ovarian cancer;Annunziata;Cancer,2010

5. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression;Basseres;Oncogene,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer;Discover Oncology;2023-08-29

2. Dysregulated Signalling Pathways Driving Anticancer Drug Resistance;International Journal of Molecular Sciences;2023-07-30

3. Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings;International Journal of Molecular Sciences;2022-10-25

4. A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming;Oncogene;2022-10-15

5. Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype;Molecular Cancer Therapeutics;2022-04-01